Susquehanna International Group
HZNP

Susquehanna International Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Susquehanna International Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-997,000
Closed -$115M – 13787
2023
Q3 		$115M Sell
997,000
-46,700
-4% -$5.02M 0.02% 555
2023
Q2 		$107M Buy
1,043,700
+956,400
+1,096% +$101M 0.02% 572
2023
Q1 		$9.53M Sell
87,300
-176,100
-67% -$19.5M ﹤0.01% 2526
2022
Q4 		$30M Buy
263,400
+27,700
+12% +$2.3M 0.01% 1198
2022
Q3 		$14.6M Buy
235,700
+111,700
+90% +$7.8M ﹤0.01% 1728
2022
Q2 		$9.89M Sell
124,000
-145,200
-54% -$13.8M ﹤0.01% 2214
2022
Q1 		$28.3M Buy
269,200
+149,800
+125% +$14.6M ﹤0.01% 1390
2021
Q4 		$12.9M Sell
119,400
-410,600
-77% -$44.8M ﹤0.01% 2374
2021
Q3 		$58.1M Buy
530,000
+4,200
+0.8% +$436K 0.01% 1064
2021
Q2 		$49.2M Buy
525,800
+283,800
+117% +$26.1M 0.01% 1213
2021
Q1 		$22.3M Sell
242,000
-208,600
-46% -$17.6M ﹤0.01% 1753
2020
Q4 		$33M Buy
450,600
+254,700
+130% +$18.9M 0.01% 1293
2020
Q3 		$15.2M Sell
195,900
-98,700
-34% -$6.79M ﹤0.01% 1754
2020
Q2 		$16.4M Buy
294,600
+54,000
+22% +$2.31M ﹤0.01% 1616
2020
Q1 		$7.13M Sell
240,600
-137,000
-36% -$4.64M ﹤0.01% 2131
2019
Q4 		$13.7M Buy
377,600
+73,600
+24% +$2.26M ﹤0.01% 1775
2019
Q3 		$8.28M Buy
304,000
+105,000
+53% +$2.71M ﹤0.01% 2175
2019
Q2 		$4.79M Sell
199,000
-233,600
-54% -$5.93M ﹤0.01% 2764
2019
Q1 		$11.4M Buy
432,600
+178,700
+70% +$4.23M ﹤0.01% 1618
2018
Q4 		$4.96M Buy
253,900
+55,400
+28% +$1.09M ﹤0.01% 2294
2018
Q3 		$3.89M Sell
198,500
-45,900
-19% -$873K ﹤0.01% 3003
2018
Q2 		$4.05M Sell
244,400
-142,900
-37% -$2.18M ﹤0.01% 2987
2018
Q1 		$5.5M Sell
387,300
-44,200
-10% -$653K ﹤0.01% 2427
2017
Q4 		$6.3M Sell
431,500
-435,800
-50% -$6.12M ﹤0.01% 2284
2017
Q3 		$11M Buy
867,300
+368,600
+74% +$4.69M ﹤0.01% 1691
2017
Q2 		$5.92M Sell
498,700
-258,500
-34% -$3.22M ﹤0.01% 2211
2017
Q1 		$11.2M Sell
757,200
-1,610,300
-68% -$26.1M 0.01% 1520
2016
Q4 		$38.3M Buy
2,367,500
+1,085,100
+85% +$19.7M 0.02% 678
2016
Q3 		$23.3M Buy
1,282,400
+886,700
+224% +$17.3M 0.01% 911
2016
Q2 		$6.52M Buy
395,700
+60,000
+18% +$971K ﹤0.01% 1884
2016
Q1 		$5.56M Sell
335,700
-472,400
-58% -$8.27M ﹤0.01% 2167
2015
Q4 		$17.5M Sell
808,100
-77,700
-9% -$1.51M 0.01% 1244
2015
Q3 		$17.6M Buy
885,800
+263,300
+42% +$8.32M 0.01% 1327
2015
Q2 		$21.6M Sell
622,500
-146,300
-19% -$4.46M 0.01% 1239
2015
Q1 		$20M Buy
768,800
+359,700
+88% +$6.59M 0.01% 1240
2014
Q4 		$5.27M Sell
409,100
-68,300
-14% -$855K ﹤0.01% 2810
2014
Q3 		$5.86M Buy
477,400
+92,800
+24% +$1.08M ﹤0.01% 2792
2014
Q2 		$6.08M Buy
384,600
+31,800
+9% +$454K ﹤0.01% 2769
2014
Q1 		$5.33M Buy
352,800
+244,300
+225% +$2.76M ﹤0.01% 2804
2013
Q4 		$827K Buy
108,500
+31,200
+40% +$168K ﹤0.01% 5828
2013
Q3 		$261K Buy
77,300
+31,600
+69% +$83.3K ﹤0.01% 7412
2013
Q2 		$112K Buy
+45,700
New +$110K ﹤0.01% 7745

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's HZNP Position: Q4 2023 in Review

Susquehanna International Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 347,967 shares — an estimated $40.3M sold.

Susquehanna International Group first reported a position in HZNP in Q2 2013 and held it in 37 quarters. The position peaked at $79.8M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Susquehanna International Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 347,967 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $40.3M.
  • Susquehanna International Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 37 quarters.
  • Susquehanna International Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $79.8M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.